News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
FDA and EMA Accept Applications for Polpharma Biologics' Vedolizumab Biosimilar PB016
Saturday, August 01, 2026Polpharma Biologics has announced that the US Food and Drug Administration FDA and the European Medicines Agency EMA have accepted for review its Biologics License Application BLA
Novo Nordisk Updates on ZEUS Phase 3 Trial of Ziltivekimab
Saturday, August 01, 2026Novo Nordisk has announced headline results from the Phase ZEUS cardiovascular outcomes trial evaluating ziltivekimab in people with atherosclerotic cardiovascular disease ASCVD chronic kidney disease CKD and inflammation
